Prostaglandin E1 administration for prevention of contrast-induced acute kidney injury: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: PGE1 has been studied for prevention of CI-AKI in several RCTs and significant heterogeneous results exist. METHODS: We searched PubMed, EMBase, and Cochrane Central Register of Controlled Trials up to December 26, 2017 for RCTs comparing PGE1 with placebo or other active medications for...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Ning, Zou, Deling, Chen, Yanli, Ren, Li, Xu, Lisheng, Pang, Wenyue, Sun, Yingxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086538/
https://www.ncbi.nlm.nih.gov/pubmed/30024512
http://dx.doi.org/10.1097/MD.0000000000011416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086538/
https://www.ncbi.nlm.nih.gov/pubmed/30024512
http://dx.doi.org/10.1097/MD.0000000000011416

Ejemplares similares